Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now later-stage tilt

Sexual Dysfunction: later-stage trial registry

7 of 21 indexed Sexual Dysfunction trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #797 of 28,707 conditions by registered trial count.

21 US clinical trials · 7 currently recruiting · #797 of 28,707 conditions by registered trial count

Sexual Dysfunction: 21 US clinical trials tracked, 7 recruiting.

Sexual Dysfunction is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition sexual-dysfunction

OPEN 7 | RECR 33% | LATE 5 | EARLY 1 | RANK #797 | SPON 3

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Anal Cancer42.9%Sexual Dysfunction (this)33%Allergic Conjunctivitis14.3%Attention Deficit Disorder W4.8%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Sexual Dysfunction

Sexual Dysfunction lists 7 open slots (33% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sexual Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sexual Dysfunction is recruiting below its size-band peers.

    7 of 21 indexed trials (33.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Sexual Dysfunction trials is spread across many organizations.

    Massachusetts General Hospital accounts for 3 of 21 trials (14.3%). 19 distinct sponsors appear on at least one study for this condition label.

  3. Most Sexual Dysfunction trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 21 trials that report a genuine target (sentinel values excluded). 14 of those (66.7%) plan for fewer than 100 participants.

  4. Sexual Dysfunction research is mostly interventional.

    19 interventional and 2 observational studies make up this index (90.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 32Phase 43

Open and recent trials

21 total, page 1 of 1

RECRUITING 10,000 participants

Blood Specimen Collection For Laboratory Assay Research

Roman Health Ventures

NCT06046651

RECRUITING Phase 1 5,000 participants

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Thomas Advanced Medical

NCT04684602

RECRUITING NA 300 participants

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Massachusetts General Hospital

NCT06541002

RECRUITING NA 60 participants

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

BTL Industries

NCT07413705

RECRUITING NA 30 participants

AYA OMGYES Sexual Health Study

University of Chicago

NCT06868121

RECRUITING NA 20 participants

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Indiana University

NCT06059586

RECRUITING NA 15 participants

Prostate Stimulation for Sexual Dysfunction

Stanford University

NCT05468931

ACTIVE NOT RECRUITING NA 230 participants

Multimodal Sexual Dysfunction Intervention In HCT

Massachusetts General Hospital

NCT03803696

ACTIVE NOT RECRUITING NA 90 participants

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Lifespan

NCT05599620

ACTIVE NOT RECRUITING NA 60 participants

Psychosexual Educational Partners Program (PEPP)

The University of Tennessee, Knoxville

NCT06253182

ACTIVE NOT RECRUITING NA 12 participants

Improving Women's Function After Pelvic Radiation

Duke University

NCT04544735

COMPLETED 2,923 participants

The Women's Urology Center/WISH Database Project

Corewell Health East

NCT00379002

COMPLETED Phase 3 242 participants

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

NCT00931528

COMPLETED Phase 4 100 participants

Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women

University of New Mexi

NCT00375297

COMPLETED NA 93 participants

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

Lelo

NCT02617472

COMPLETED NA 62 participants

A Mindfulness-based Intervention for Older Women With Low Sexual Desire

University of Pittsburgh

NCT03232801

COMPLETED NA 60 participants

Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause

Sciton

NCT03178825

COMPLETED Phase 3 20 participants

Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction

Massachusetts General Hospital

NCT00181961

COMPLETED NA 15 participants

Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

University of Wisconsin, Madison

NCT02096783

COMPLETED Phase 4 15 participants

Wellbutrin XL Effects on SSRIs Induced Changes

Indiana University School of Medicine

NCT00456820

COMPLETED Phase 4 9 participants

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

St. Luke's-Roosevelt Hospital Center

NCT00334048

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Sexual Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Hybrid Fractional Laser Device
1 trials
Maca Root Drug
1 trials
general health education group Behavioral
1 trials
mindfulness-based multicomponent intervention Behavioral
1 trials
Wellbutrin XL Drug
1 trials
Ropinirole (Requip) Drug
1 trials
Pelvic floor exerciser Device
1 trials
informational intervention Other
1 trials

US sites by state

Facility locations filed on Sexual Dysfunction trials. A trial with sites in several states counts in each.

California 5 trials
Massachusetts 4 trials
Florida 3 trials
Pennsylvania 2 trials
North Carolina 2 trials
Indiana 2 trials
Arizona 2 trials
Wisconsin 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sexual Dysfunction page

21 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sexual Dysfunction condition card totals 21 registered trials; most-linked intervention Hybrid Fractional Laser; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.